Saturday 17 October 2026
Export YTENQ’s income statement to Excel — free account
Metabolix, Inc.
YTENQ Basic Materials Agricultural Inputs
Metabolix, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $60,000.00, down 86.7% from fiscal 2022. Operating cash flow growth for three consecutive years.
0.00
0.00
NaN
Follow YTENQ
| Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
2 | 2 | 4 | 4 | 4 | 3 | 3 | 2 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
(161.45) | (72.80) | (24.28) | (35.93) | (31.45) | (39.22) | (28.27) | (44.56) |
P/S ratio |
5.54 | 18.70 | 37.94 | 17.19 | 3.10 | 14.90 | 7.09 | 8.43 |
Altman Z″-Score (non-manufacturers) |
(376.59) | (168.33) | (56.89) | (82.79) | (71.10) | (90.14) | (60.81) | (102.88) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(1.17) | (2.75) | (9.38) | (6.90) | (0.78) | (4.10) | (3.53) | (4.04) |
Beneish M-Score |
— | (4.83) | (2.08) | (2.79) | (3.98) | 4.13 | (3.22) | (0.87) |
P/B ratio |
0.00 | 1.91 | 1.45 | 1.44 | 0.00 | 1.45 | 0.53 | 1.53 |
Price to Tangible BV |
0.00 | 1.91 | 1.45 | 1.44 | 0.00 | 1.45 | 0.53 | 1.53 |
EV/Sales |
5.27 | 13.65 | 16.22 | 9.00 | (6.20) | 14.64 | (7.16) | 3.10 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.60 | 0.00 | 0.74 | 0.00 |
EV/Operating CF |
(0.19) | (0.54) | (1.08) | (0.83) | 0.58 | (0.93) | 0.82 | (0.25) |
EV/FCF |
(0.19) | (0.53) | (1.05) | (0.82) | 0.57 | (0.93) | 0.79 | (0.24) |
Quick Ratio |
0.22 | 2.72 | 9.34 | 5.41 | 5.08 | 3.61 | 6.15 | 2.72 |
Current Ratio |
0.29 | 3.12 | 9.59 | 5.70 | 5.29 | 3.89 | 6.28 | 2.85 |
Net Debt/EBITDA |
0.08 | 0.33 | 1.39 | 1.03 | 1.32 | 0.63 | 1.60 | 0.63 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 10.53% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.18 |
Asset Turnover |
0.01 | 0.03 | 0.04 | 0.05 | 0.05 | 0.04 | 0.07 | 0.08 |
Operating CF/Net income |
0.70 | 0.84 | 0.84 | 0.85 | 0.67 | 0.95 | 0.76 | 1.89 |
Capex/Depreciation |
(0.16) | (0.59) | (0.86) | (0.36) | (0.30) | (0.21) | (0.03) | (1.46) |
| (1,508.09%) | (132.83%) | (86.32%) | (374.74%) | (1,606.45%) | (99.93%) | (113.61%) | (78.40%) | |
| (241.08%) | (95.20%) | (63.15%) | (65.34%) | (87.31%) | (61.56%) | (78.34%) | (54.63%) | |
ROIC |
0.00% | (15,862.03%) | (20,298.61%) | 0.00% | 0.00% | 0.00% | 0.00% | (3,335.94%) |
Return on Tangible Assets |
495.54% | (324.31%) | (69.90%) | (108.01%) | (120.86%) | (150.06%) | (76.86%) | (111.15%) |
Average Days of Receivables |
0.00 | 24.33 | 117.70 | 51.62 | 41.66 | 105.04 | 46.01 | 59.21 |
Research and Development Expense of Revenue |
13,871.67% | 1,722.22% | 1,009.93% | 670.96% | 601.49% | 860.25% | 486.97% | 489.21% |
Selling, General and Administrative Expense of Revenue |
10,256.67% | 1,366.89% | 994.30% | 631.66% | 565.01% | 915.83% | 596.40% | 495.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
2,653.33% | 422.89% | 272.80% | 92.49% | 81.39% | 212.41% | 147.78% | 73.17% |
Graham Net Nets |
(2.49) | 0.16 | 0.53 | 0.39 | (3.64) | (0.11) | 1.72 | 0.36 |
Graham Number |
91.71 | 0.00 | 0.00 | 0.00 | 2,277.61 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(825.83%) | (161.27%) | (47.52%) | (81.25%) | (521.07%) | (111.96%) | (157.92%) | (82.56%) |
Free Cash Flow Yield |
(505.43%) | (137.38%) | (40.53%) | (63.53%) | (348.25%) | (106.15%) | (128.09%) | (155.10%) |
Revenue per Share |
0.18 | 2.20 | 3.11 | 8.07 | 53.03 | 53.46 | 277.65 | 399.66 |
Operating CF per Share |
(30.39) | (55.63) | (46.90) | (87.46) | (569.34) | (841.73) | (2,412.35) | (4,966.90) |
Capex per Share |
(0.14) | (0.75) | (0.96) | (0.67) | (4.01) | (4.04) | (1.76) | (259.31) |
Free Cash Flow per Share |
(30.53) | (56.38) | (47.86) | (88.13) | (573.36) | (845.77) | (2,414.12) | (5,226.21) |
Cash per Share |
3.22 | 21.20 | 81.04 | 98.00 | 731.38 | 554.71 | 4,260.88 | 2,520.34 |
Shareholders Equity per Share |
(7.49) | 21.46 | 81.23 | 96.28 | (268.75) | 547.88 | 3,971.18 | 2,196.21 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(7.49) | 21.46 | 81.23 | 96.28 | (268.75) | 547.88 | 3,971.18 | 2,196.21 |
Free Cash Flow |
(10.11) | (11.56) | (9.44) | (8.72) | (8.71) | (8.80) | (8.21) | (15.16) |
Working Capital |
(3.46) | 3.41 | 14.89 | 8.53 | 9.48 | 4.74 | 12.54 | 5.10 |
Capital Expenditures |
(0.05) | (0.15) | (0.19) | (0.07) | (0.06) | (0.04) | (0.01) | (0.75) |
Net Current Asset Value |
(4.99) | 1.33 | 12.24 | 5.35 | (9.12) | (0.88) | 11.54 | 3.48 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.58 | 0.00 | 0.73 | 0.00 |
Capex to Sales |
0.77 | 0.34 | 0.31 | 0.08 | 0.08 | 0.08 | 0.01 | 0.65 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||
Depreciation/Fixed assets |
0.53 | 0.34 | 0.25 | 0.20 | 0.16 | 0.14 | 0.13 | 0.30 |
Cash ROIC |
714.77% | (132.14%) | (29.49%) | (45.36%) | (123.93%) | (76.71%) | (29.33%) | (102.34%) |
Accounts Receivable Turnover |
0.00 | 3.95 | 3.95 | 7.80 | 6.40 | 3.99 | 6.15 | 3.21 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | 0.00 | 0.00 | — | — | — | — | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | 0.00 | 0.00 | — | — | — | — | 0.00 |
Average Receivables |
— | 0.11 | 0.16 | 0.10 | 0.13 | 0.14 | 0.15 | 0.36 |
Average Payables |
0.66 | 0.10 | 0.07 | 0.17 | 0.20 | 0.10 | 0.07 | 0.09 |
Average Inventory |
— | — | — | — | — | — | — | 0.12 |
Average Assets |
6.00 | 14.25 | 17.47 | 15.62 | 14.84 | 14.92 | 13.82 | 13.92 |
Average Common Equity |
0.96 | 10.21 | 12.78 | 2.72 | 0.81 | 9.19 | 9.53 | 9.70 |
Columns are period end dates